<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
    <channel>
        <title>Nova Reader - Subject</title>
        <link>https://www.novareader.co</link>
        <description>Default RSS Feed</description>
        <language>en-us</language>
        <copyright>Newgen KnowledgeWorks</copyright>
        <item>
            <title><![CDATA[Incorporating equity, diversity, and inclusiveness into the Hong Kong Principles]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766067720038-94014746-d83a-4b14-875a-9ae8976210c8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pbio.3001140</link>
            <description><![CDATA[<p class="para" id="N65540">In this response to Labib and Evans, authors of the Hong Kong Principles look forward to collaborating with those from the broad research integrity community to ensure that issues of equity, diversity and inclusion will become part of the ecosystem of research integrity.</p>]]></description>
            <pubDate><![CDATA[2021-04-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Gender, diversity, and the responsible assessment of researchers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766067279595-7c2b1457-17f4-4c3a-8649-b27c835c7b2f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pbio.3001036</link>
            <description><![CDATA[<p class="para" id="N65540">In response to the Hong Kong Principles for assessing researchers, this Formal Comment argues that it is time to take gender and diversity considerations seriously in the pursuit of fostering research integrity; this requires acknowledging and reshaping the influence of research assessment criteria on researcher representation.</p>]]></description>
            <pubDate><![CDATA[2021-04-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Comment on the paper "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results"]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765924468913-3d0ab2c9-3452-4644-9b5e-e81c33bb9608/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1371/journal.pone.0245480</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-02-18T00:00]]></pubDate>
        </item>
    </channel>
</rss>